Weight loss
Orforglipron for weight loss
Weight loss medication
Other names: Foundayo, orforglipron
Taken for: Weight lossTaking it for something else? The entries here do not cover that use. The FAA may address it in the guidance for your condition. Ask your examiner.
Wait
One week after starting
Different waits apply in other cases.
Examiner
CACI: the examiner can issue when the condition's worksheet criteria are met. Applicants for first- or second-class must provide the worksheet's information annually; applicants for third-class with each required exam
The FAA's CACI – Weight Loss Management worksheet says the examiner can issue if the applicant meets all the acceptable certification criteria it lists.
Track your medicationsCompare FAA documents: orforglipron for weight lossWhat each of the two FAA documents says, in plain wordsOpen
Wait
- 48 hours after each dose increase, medication or formulation change
It names orforglipron (Foundayo) among the medications it lists, says only one of the medications listed is used, and says the examiner should verify a one-week observation after starting medication, and lists a 48-hour observation with each dose increase, medication or formulation change.
The FAA's Weight Loss Medication sheet, which the worksheet points to, does not list orforglipron among its acceptable weight loss medications.
- 7 days after starting: ground observation
- 48 hours after a dose change: ground observation
Show the FAA's words: orforglipron for weight lossThe official FAA wording: two passages, each with its document and dateOpen
If the applicant meets ALL the acceptable certification criteria listed below, the Examiner can issue.
ONLY ONE of the medications listed is used:
AME should verify one-week observation after starting medication. (See Pharmaceuticals, Weight Loss Medication.) 48-hour observation with each dose increase, medication or formulation change.
Indicate which one medication is used:
metformin OR
liraglutide OR
orforglipron (Foundayo)
semaglutide* (Wegovy) OR
tirzepatide (Zepbound)
ACCEPTABLE Weight Loss Medications
When certification criteria are met.
Medication Drug Class Initial observation
Lipase inhibitors – e.g., orlistat [Alli; Xenical] - OTC
48 hours
Treated with a single diabetic medication component:
metformin
GLP-1 agonist
liraglutide
semaglutide (Wegovy) [injection or oral]
tirzepatide (Zepbound) [GIP + GLP-1 Agonist]
Combination of the following (only one diabetic medication):
orlistat + metformin
orlistat + GLP-1 agonist